Page last updated: 2024-11-02

phloretin and Osteosarcoma

phloretin has been researched along with Osteosarcoma in 2 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Osteosarcoma is the most common primary malignancy of bone."1.40Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells. ( Fu, WM; Hsieh, IS; Yang, RS, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ogawa, T1
Sasaki, A1
Ono, K1
Ohshika, S1
Ishibashi, Y1
Yamada, K1
Hsieh, IS1
Yang, RS1
Fu, WM1

Other Studies

2 other studies available for phloretin and Osteosarcoma

ArticleYear
Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
    Human cell, 2021, Volume: 34, Issue:2

    Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Bone Neoplasms; Cytochalasin B; Deoxyglucose; Depression, Che

2021
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Gluc

2014